Thomas S. McHugh, Chief Financial Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 50,000 shares at $2.14 ($107K) on 2022-05-27, disclosed to the SEC on 2022-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |
| AVDL | BUY | 2024-01-16 | $29K | — | Filing → |
| AVDL | BUY | 2023-08-14 | $29K | — | Filing → |
| AVDL | BUY | 2022-11-30 | $39K | — | Filing → |